Robotic Surgery in Obese Prostate Cancer Patients Reduces Blood Loss, Hospital Length

Robotic Surgery in Obese Prostate Cancer Patients Reduces Blood Loss, Hospital Length
Researchers at Loyola University Chicago Stritch School of Medicine found that robotic-assisted surgery to remove the prostate in obese prostate cancer patients reduces the length of hospital stays and lowers the risk of blood loss, compared to open prostatectomy. The findings were published in Current Urology in a study titled "Open Versus Robotic Radical Prostatectomy in Obese Men." Prostate cancer is the most common cancer in men in the United States. A large number of patients that develop the disease choose radical prostatectomy (removal of the prostate gland and surrounding tissue) for treatment. In the past decade, robotic-assisted prostatectomy has been shown to reduce blood loss, length of stay, and peri-operative complications, and its use has surpassed that of open surgery. Approximately 40 percent of adults in the U.S. are obese. For these patients, surgical interventions and perioperative care is often challenging because many exhibit obesity-related diseases, such as hypertension, diabetes, heart disease, and obstructive sleep apnea, that increase the risk of complications, blood transfusions, and prolonged hospital stays. To address whether robotic-assisted surgery could benefit obese patients, the research team, led by Gopal Gupta, M.D., an assistant professor in the Department of Urology at Stritch School of Medicine, examined records from the 2009-2010 Nationwide Inpatient Sample, which included data from hospitals in 44 states, and identified obese men with prostate cancer who underwent open or robotic-ass
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *